Acerus Pharmaceuticals's basic eps (cont. ops) hit its 5-year low in December 2020 of -6.37. Acerus Pharmaceuticals's basic eps (cont. ops) increased in 2020 (-6.37, -61.2%) and 2021 (-5.56, -12.7%).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results